@article{a58fa8472207459d85b32084c75261ec,
title = "Knowledge and attitudes of Parkinson{\textquoteright}s disease risk in the Gaucher population",
abstract = "Individuals with Gaucher disease have an increased risk of developing Parkinson's disease as compared to the general population. Though the association is well-known in the scientific community, it is unclear if individuals with Gaucher disease are being counseled on the increased risk. To date, no studies have been performed assessing whether Gaucher disease patients are aware of the increased risk of developing Parkinson's disease. Furthermore, it is unknown how and when individuals with Gaucher disease wish to learn of the increased risk. To assess this, an online survey was administered to Gaucher disease patients. We hypothesized that most individuals with Gaucher disease have been informed of the risk, and that they wish to be told of the risk by their health care provider at the time of diagnosis. Study results revealed that of 125 individuals with Gaucher disease, 80% previously knew about the association with Parkinson's disease, 83.7% preferred to find out about the increased risk from a health care provider, and 71.0% wanted to find out at the time of Gaucher disease diagnosis. These results suggest that health care providers should counsel Gaucher disease patients about the increased Parkinson's disease risk, and they should do so at the time of diagnosis.",
keywords = "Gaucher disease, Parkinson's disease, attitudes, counseling, genetic counseling, increased risk, risk perception",
author = "Leah Zaretsky and Natasha Zeid and Hetanshi Naik and Alcalay, {Roy N.} and Manisha Balwani",
note = "Funding Information: Author Leah Zaretsky declares no conflict. Author Natasha Zeid has received an honorarium for a lecture given at a meeting sponsored by Sanofi Genzyme. Author Hetanshi Naik declares no conflict. Author Roy N. Alcalay is supported by the Parkinson's Disease Foundation, the National Institutes of Health, and the Michael J. Fox Foundation. He consulted and received travel reimbursement from Sanofi Genzyme, ProPhase, and Denali Therapeutics. Author Manisha Balwani is a member of the International Collaborative Gaucher Group North America board of advisors. She has received honoraria and travel reimbursement from Genzyme and Shire for advisory board participation. Funding Information: This study was performed as part of a thesis project to fulfill a degree requirement at the Icahn School of Medicine at Mount Sinai. We would like to thank the patients of the Lysosomal Storage Disease Program at Mount Sinai. We would like to thank the following individuals at the National Gaucher Foundation: Amy Blum, Chief Operating Officer, and Samantha Rubinstein, Vice President of Education, Awareness, and Patient Advocacy. We would also like to thank the members of the National Gaucher Foundation. Publisher Copyright: {\textcopyright} 2019 National Society of Genetic Counselors",
year = "2020",
month = feb,
day = "1",
doi = "10.1002/jgc4.1185",
language = "English",
volume = "29",
pages = "105--111",
journal = "Journal of Genetic Counseling",
issn = "1059-7700",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "1",
}